EDITORIAL
Published on 11 Jun 2024
Editorial: Editor's challenge: Dr. Qingxin Mu - how can nanomedicine approaches advance multi-targeting strategy in combination cancer therapy?
doi 10.3389/fonc.2024.1437497
- 357 views
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Research Topics
- Editor's Challenge: Dr. Qingxin Mu - How can Nanomedicine Approaches Advance Multi-targeting Strategy in Combination Cancer Therapy?
Editor's Challenge: Dr. Qingxin Mu - How can Nanomedicine Approaches Advance Multi-targeting Strategy in Combination Cancer Therapy?
3,518
Total downloads
14k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
MINI REVIEW
Published on 02 May 2024
Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer
doi 10.3389/fonc.2024.1393492
- 1,270 views
REVIEW
Published on 15 Dec 2023
Autophagy-mediated nanomaterials for tumor therapy
doi 10.3389/fonc.2023.1194524
- 1,511 views
- 2 citations
ORIGINAL RESEARCH
Published on 31 Aug 2023
Secretome profiling of Artemisia absinthium extract-loaded polymeric nanoparticle-treated MCF-7 and MDA-MB-231 revealed perturbation in microtubule assembly and cell migration
doi 10.3389/fonc.2023.1209168
- 2,513 views
ORIGINAL RESEARCH
Published on 17 Aug 2023
Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells
doi 10.3389/fonc.2023.1193708
- 1,475 views
- 7 citations
ORIGINAL RESEARCH
Published on 02 Feb 2023
Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1
doi 10.3389/fonc.2023.1112859
- 2,417 views
- 6 citations
Published in
Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
Participating Journals
Frontiers in Pharmacology
Cancer Molecular Targets and TherapeuticsOffline
- 4.4 impact factor
- 7.8 citescore
Impact
- 14kTopic views
- 7,624Article views
- 3,518Article downloads